{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:40:34Z","timestamp":1789202434766,"version":"build-2803163510"},"reference-count":79,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["AI155865"],"award-info":[{"award-number":["AI155865"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"crossref","award":["AR068383"],"award-info":[{"award-number":["AR068383"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020366","name":"MassCPR","doi-asserted-by":"crossref","award":["Evergrande COVID\u201019 Response Fund Award"],"award-info":[{"award-number":["Evergrande COVID\u201019 Response Fund Award"]}],"id":[{"id":"10.13039\/100020366","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cancer Research Institute","award":["CRI2453"],"award-info":[{"award-number":["CRI2453"]}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,6,28]]},"abstract":"<jats:sec id=\"abs1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Although there are several efficacious vaccines against COVID-19, vaccination rates in many regions around the world remain insufficient to prevent continued high disease burden and emergence of viral variants. Repurposing of existing therapeutics that prevent or mitigate severe COVID-19 could help to address these challenges. The objective of this study was to determine whether prior use of bisphosphonates is associated with reduced incidence and\/or severity of COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective cohort study utilizing payer-complete health insurance claims data from 8,239,790 patients with continuous medical and prescription insurance January 1, 2019 to June 30, 2020 was performed. The primary exposure of interest was use of any bisphosphonate from January 1, 2019 to February 29, 2020. Bisphosphonate users were identified as patients having at least one bisphosphonate claim during this period, who were then 1:1 propensity score-matched to bisphosphonate non-users by age, gender, insurance type, primary-care-provider visit in 2019, and comorbidity burden. Main outcomes of interest included: (a) any testing for SARS-CoV-2 infection; (b) COVID-19 diagnosis; and (c) hospitalization with a COVID-19 diagnosis between March 1, 2020 and June 30, 2020. Multiple sensitivity analyses were also performed to assess core study outcomes amongst more restrictive matches between BP users\/non-users, as well as assessing the relationship between BP-use and other respiratory infections (pneumonia, acute bronchitis) both during the same study period as well as before the COVID outbreak.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 7,906,603 patients for whom continuous medical and prescription insurance information was available were selected. A total of 450,366 bisphosphonate users were identified and 1:1 propensity score-matched to bisphosphonate non-users. Bisphosphonate users had lower odds ratios (OR) of testing for SARS-CoV-2 infection (OR = 0.22; 95%CI:0.21\u20130.23; p&lt;0.001), COVID-19 diagnosis (OR = 0.23; 95%CI:0.22\u20130.24; p&lt;0.001), and COVID-19-related hospitalization (OR = 0.26; 95%CI:0.24\u20130.29; p&lt;0.001). Sensitivity analyses yielded results consistent with the primary analysis. Bisphosphonate-use was also associated with decreased odds of acute bronchitis (OR = 0.23; 95%CI:0.22\u20130.23; p&lt;0.001) or pneumonia (OR = 0.32; 95%CI:0.31\u20130.34; p&lt;0.001) in 2019, suggesting that bisphosphonates may protect against respiratory infections by a variety of pathogens, including but not limited to SARS-CoV-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs4\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Prior bisphosphonate-use was associated with dramatically reduced odds of SARS-CoV-2 testing, COVID-19 diagnosis, and COVID-19-related hospitalizations. Prospective clinical trials will be required to establish a causal role for bisphosphonate-use in COVID-19-related outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs5\">\n                    <jats:title>Funding:<\/jats:title>\n                    <jats:p>This study was supported by NIH grants, AR068383 and AI155865, a grant from MassCPR (to UHvA) and a CRI Irvington postdoctoral fellowship, CRI2453 (to PH).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7554\/elife.79548","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T08:10:13Z","timestamp":1691050213000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.79548","source":"Crossref","is-referenced-by-count":11,"title":["Association between bisphosphonate use and COVID-19 related outcomes"],"prefix":"10.7554","volume":"12","author":[{"given":"Jeffrey","family":"Thompson","sequence":"first","affiliation":[{"name":"Cerner Enviza","place":["Malvern, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidi","family":"Wang","sequence":"first","affiliation":[{"name":"Dept. of Immunology, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Dreischulte","sequence":"additional","affiliation":[{"name":"Institute of General Practice and Family Medicine, University Hospital of Ludwig Maximilians-University Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Barreiro","sequence":"additional","affiliation":[{"name":"Dept. of Immunology, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo J","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Dept. of Immunology, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Han\u010d","sequence":"additional","affiliation":[{"name":"Dept. of Immunology, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Matysiak","sequence":"additional","affiliation":[{"name":"Dept. of Immunology, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold R","family":"Neely","sequence":"additional","affiliation":[{"name":"Dept. of Immunology, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marietta","family":"Rottenkolber","sequence":"additional","affiliation":[{"name":"Institute of General Practice and Family Medicine, University Hospital of Ludwig Maximilians-University Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Haskell","sequence":"additional","affiliation":[{"name":"Cerner Enviza","place":["Malvern, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4703-537X","authenticated-orcid":true,"given":"Stefan","family":"Endres","sequence":"additional","affiliation":[{"name":"Center of Integrated Protein Science Munich and Division of Clinical Pharmacology, University Hospital, LMU Munich, Germany","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4231-2283","authenticated-orcid":true,"given":"Ulrich H","family":"von Andrian","sequence":"additional","affiliation":[{"name":"Dept. of Immunology, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08649-9","article-title":"Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells","volume":"7","author":"Abdullah","year":"2017","journal-title":"Scientific Reports"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00198-021-06067-2","article-title":"No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study","volume":"33","author":"Atmaca","year":"2022","journal-title":"Osteoporosis International"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1377\/hlthaff.2020.00598","article-title":"Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California","volume":"39","author":"Azar","year":"2020","journal-title":"Health Affairs"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"19923","DOI":"10.18632\/aging.104117","article-title":"Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions","author":"Blanch-Rubi\u00f3","year":"2020","journal-title":"Aging"},{"key":"bib6","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02433-6","article-title":"Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection","volume":"18","author":"Brufsky","year":"2020","journal-title":"Journal of Translational Medicine"},{"key":"bib7","article-title":"United States COVID-19 Cases and Death by State Over Time","author":"CDC","year":"2021","unstructured":"CDC. 2021a. United States COVID-19 Cases and Death by State Over Time. https:\/\/www.cdc.gov\/nchs\/pressroom\/sosmap\/covid19_mortality_final\/COVID19.htm [Accessed August 1, 2021]."},{"key":"bib8","article-title":"Risk for COVID-19 Infection, Hospitalization, and Death By Race\/Ethnicity","author":"CDC","year":"2021","unstructured":"CDC. 2021b. Risk for COVID-19 Infection, Hospitalization, and Death By Race\/Ethnicity. https:\/\/stacks.cdc.gov\/view\/cdc\/105453 [Accessed April 23, 2021]."},{"key":"bib9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75272-6","article-title":"The effect of pamidronate delivery in bisphosphonate-na\u00efve patients on neutrophil chemotaxis and oxidative burst","volume":"10","author":"Chadwick","year":"2020","journal-title":"Scientific Reports"},{"key":"bib10","first-page":"155","article-title":"Racial and ethnic disparities in antidepressant drug use","volume":"11","author":"Chen","year":"2008","journal-title":"The Journal of Mental Health Policy and Economics"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1359\/jbmr.090704","article-title":"Potential mediators of the mortality reduction with zoledronic acid after hip fracture","volume":"25","author":"Col\u00f3n-Emeric","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/bcp.13867","article-title":"Pharmacology of bisphosphonates","volume":"85","author":"Cremers","year":"2019","journal-title":"British Journal of Clinical Pharmacology"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MLR.0b013e318207ed9e","article-title":"Placebo adherence, clinical outcomes, and mortality in the women\u2019s health initiative randomized hormone therapy trials","volume":"49","author":"Curtis","year":"2011","journal-title":"Medical Care"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1002\/jbmr.4419","article-title":"The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes","volume":"36","author":"Degli Esposti","year":"2021","journal-title":"Journal of Bone and Mineral Research"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1200\/JCO.2016.70.7257","article-title":"Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: A Cancer care ontario and american society of clinical oncology clinical practice guideline","volume":"35","author":"Dhesy-Thind","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.108.824151","article-title":"Statin adherence and risk of accidents: a cautionary tale","volume":"119","author":"Dormuth","year":"2009","journal-title":"Circulation"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1056\/NEJMsb2005114","article-title":"Fair Allocation of Scarce Medical Resources in the Time of Covid-19","volume":"382","author":"Emanuel","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"786","DOI":"10.7326\/M20-6979","article-title":"Racial Disparities in COVID-19 Testing and Outcomes","volume":"174","author":"Escobar","year":"2021","journal-title":"Annals of Internal Medicine"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ijom.2012.12.011","article-title":"The effect of bisphosphonate therapy on neutrophil function: a potential biomarker","volume":"42","author":"Favot","year":"2013","journal-title":"International Journal of Oral and Maxillofacial Surgery"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1210\/jc.2015-2680","article-title":"Short-term safety of zoledronic acid in young patients with bone disorders: An extensive institutional experience","volume":"100","author":"George","year":"2015","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"bib21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.116.003166","article-title":"Racial and Ethnic Differences in Antihypertensive Medication Use and Blood Pressure Control Among US Adults With Hypertension","volume":"10","author":"Gu","year":"2017","journal-title":"Circulation"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.chom.2010.04.006","article-title":"Antiviral instruction of bone marrow leukocytes during respiratory viral infections","volume":"7","author":"Hermesh","year":"2010","journal-title":"Cell Host & Microbe"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2249.2005.02665.x","article-title":"The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins","volume":"139","author":"Hewitt","year":"2005","journal-title":"Clinical and Experimental Immunology"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1038\/s41380-021-01021-4","article-title":"Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study","volume":"26","author":"Hoertel","year":"2021","journal-title":"Molecular Psychiatry"},{"key":"bib25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68165","article-title":"Identification of drugs associated with reduced severity of COVID-19 - a case-control study in a large population","volume":"10","author":"Israel","year":"2021","journal-title":"eLife"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.amepre.2021.05.015","article-title":"Racial and Ethnic Disparities in SARS-CoV-2 Testing and COVID-19 Outcomes in a Medicaid Managed Care Cohort","volume":"61","author":"Jacobson","year":"2021","journal-title":"American Journal of Preventive Medicine"},{"key":"bib28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.36462","article-title":"Association of Social and Demographic Factors With COVID-19 Incidence and Death Rates in the US","volume":"4","author":"Karmakar","year":"2021","journal-title":"JAMA Network Open"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/pop.2020.0163","article-title":"Disparities in SARS-CoV-2 Positivity Rates: Associations with Race and Ethnicity","volume":"24","author":"Kaufman","year":"2021","journal-title":"Population Health Management"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"7829","DOI":"10.1073\/pnas.0601643103","article-title":"The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs","volume":"103","author":"Kavanagh","year":"2006","journal-title":"PNAS"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/pds.5401","article-title":"Validation of diagnosis codes to identify hospitalized COVID-19 patients in health care claims data","volume":"31","author":"Kluberg","year":"2022","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1476-5381.2011.01592.x","article-title":"Zoledronate and pamidronate depress neutrophil functions and survival in mice","volume":"165","author":"Kuiper","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/jep.12095","article-title":"Healthy adherer effect - the pitfall in the interpretation of the effect of medication adherence on health outcomes","volume":"20","author":"Ladova","year":"2014","journal-title":"Journal of Evaluation in Clinical Practice"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1210\/jc.2015-3467","article-title":"Preadmission bisphosphonate and mortality in critically ill patients","volume":"101","author":"Lee","year":"2016","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"bib35","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-016-0183-7","article-title":"Immune modulation of CD4+CD25+ regulatory T cells by zoledronic acid","volume":"17","author":"Liu","year":"2016","journal-title":"BMC Immunology"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jacl.2021.03.002","article-title":"Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching","volume":"15","author":"Lohia","year":"2021","journal-title":"Journal of Clinical Lipidology"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.immuni.2005.01.008","article-title":"Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells","volume":"22","author":"Mazo","year":"2005","journal-title":"Immunity"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1182\/bloodadvances.2020003568","article-title":"A neutrophil activation signature predicts critical illness and mortality in COVID-19","volume":"5","author":"Meizlish","year":"2021","journal-title":"Blood Advances"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment","volume":"7","author":"Migliorati","year":"2006","journal-title":"The Lancet. Oncology"},{"key":"bib40","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.21892","article-title":"Racial Disparities in Incidence and Outcomes Among Patients With COVID-19","volume":"3","author":"Mu\u00f1oz-Price","year":"2020","journal-title":"JAMA Network Open"},{"key":"bib41","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0209-6","article-title":"Enhancing adoptive cancer immunotherapy with V\u03b32V\u03b42 T cells through pulse zoledronate stimulation","volume":"5","author":"Nada","year":"2017","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.7326\/M20-8283","article-title":"COVID-19 Inequities Across Multiple Racial and Ethnic Groups: Results From an Integrated Health Care Organization","volume":"174","author":"Nau","year":"2021","journal-title":"Annals of Internal Medicine"},{"key":"bib43","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7019a5","article-title":"QuickStats: Percentage* of Adults Aged \u226550 Years with Osteoporosis,\u2020 by Race and Hispanic 1285 Origin\u00a7 \u2014 United States, 2017\u20132018","volume":"70","author":"No authors listed","year":"2021","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"bib44","article-title":"Reducing bias in a propensity score matched-pair sample using greedy matching techniques","author":"Parsons","year":"2001","unstructured":"Parsons LS. 2001. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. The Twenty-Sixth Annual SAS Users Group International Conference."},{"key":"bib45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/0962280210386207","article-title":"Diagnosing and responding to violations in the positivity assumption","volume":"21","author":"Petersen","year":"2012","journal-title":"Statistical Methods in Medical Research"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1086\/502975","article-title":"Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells","volume":"193","author":"Poccia","year":"2006","journal-title":"The Journal of Infectious Diseases"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMsa2011686","article-title":"Hospitalization and Mortality among Black Patients and White Patients with Covid-19","volume":"382","author":"Price-Haywood","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Medical Care"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00223-021-00830-7","article-title":"Effect of zoledronate on lower respiratory infections in older women: secondary analysis of a randomized controlled trial","volume":"109","author":"Reid","year":"2021","journal-title":"Calcified Tissue International"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1377\/hlthaff.2021.00098","article-title":"Racial\/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California","volume":"40","author":"Reitsma","year":"2021","journal-title":"Health Affairs"},{"key":"bib51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652470","article-title":"Neutrophils in COVID-19","volume":"12","author":"Reusch","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41577-020-00452-4","article-title":"\u03b3\u03b4 T cells in tissue physiology and surveillance","volume":"21","author":"Ribot","year":"2021","journal-title":"Nature Reviews. Immunology"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1359\/jbmr.091009","article-title":"Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo","volume":"25","author":"Roelofs","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.2174\/138161210793563635","article-title":"Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages","volume":"16","author":"Roelofs","year":"2010","journal-title":"Current Pharmaceutical Design"},{"key":"bib55","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-177","article-title":"Tumour macrophages as potential targets of bisphosphonates","volume":"9","author":"Rogers","year":"2011","journal-title":"Journal of Translational Medicine"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/wmh3.358","article-title":"Racial Disparities in COVID-19 Mortality Among Essential Workers in the United States","volume":"12","author":"Rogers","year":"2020","journal-title":"World Medical & Health Policy"},{"key":"bib57","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.29058","article-title":"Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19","volume":"3","author":"Rosenthal","year":"2020","journal-title":"JAMA Network Open"},{"key":"bib58","article-title":"COVID-19 Racial Disparities in Testing, Infection, Hospitalization, and Death: Analysis of Epic Patient Data","author":"Rubin-Miller","year":"2020","unstructured":"Rubin-Miller L. 2020. COVID-19 Racial Disparities in Testing, Infection, Hospitalization, and Death: Analysis of Epic Patient Data. https:\/\/www.kff.org\/coronavirus-covid-19\/issue-brief\/covid-19-racial-disparities-testing-infection-hospitalization-death-analysis-epic-patient-data [Accessed September 10, 2021]."},{"key":"bib59","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1542\/peds.2006-2023H","article-title":"Bisphosphonates: mode of action and pharmacology","volume":"119","author":"Russell","year":"2007","journal-title":"Pediatrics"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporosis International"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/2040622315584114","article-title":"Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications","volume":"6","author":"Saita","year":"2015","journal-title":"Therapeutic Advances in Chronic Disease"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jamacardio.2016.4700","article-title":"National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey","volume":"2","author":"Salami","year":"2017","journal-title":"JAMA Cardiology"},{"key":"bib63","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1338238","article-title":"Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer","volume":"6","author":"Sarhan","year":"2017","journal-title":"Oncoimmunology"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1442-200X.2010.03174.x","article-title":"Zoledronic acid for the treatment of osteopenia in pediatric Crohn\u2019s disease","volume":"52","author":"Sbrocchi","year":"2010","journal-title":"Pediatrics International"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1377\/hlthaff.2020.00897","article-title":"COVID-19 And Racial\/Ethnic Disparities In Health Risk, Employment, And Household Composition","volume":"39","author":"Selden","year":"2020","journal-title":"Health Affairs"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/jbmr.4030","article-title":"Nitrogen-containing bisphosphonates are associated with reduced risk of pneumonia in patients with hip fracture","volume":"35","author":"Sing","year":"2020","journal-title":"Journal of Bone and Mineral Research"},{"key":"bib67","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.588654","article-title":"Challenges for Drug Repurposing in the COVID-19 Pandemic Era","volume":"11","author":"Sultana","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"bib68","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/rheumatology\/ket236","article-title":"Safety issues with bisphosphonate therapy for osteoporosis","volume":"53","author":"Suresh","year":"2014","journal-title":"Rheumatology"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.celrep.2013.09.004","article-title":"Bisphosphonates target B cells to enhance humoral immune responses","volume":"5","author":"Tonti","year":"2013","journal-title":"Cell Reports"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1084\/jem.20110226","article-title":"The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice","volume":"208","author":"Tu","year":"2011","journal-title":"The Journal of Experimental Medicine"},{"key":"bib71","article-title":"QuickFacts California - Race and Hispanic Origin","volume-title":"United States Census Bureau","author":"United States Census Bureau","year":"2019","unstructured":"United States Census Bureau. 2019. QuickFacts California - Race and Hispanic Origin. United States Census Bureau. https:\/\/www.census.gov\/quickfacts\/CA [Accessed September 7, 2019]."},{"key":"bib72","article-title":"BLS Reports October 2019: Labor force characteristics by race and ethnicity, 2018","volume-title":"United States Department of Labor","author":"US Bureau of Labor Statistics","year":"2019","unstructured":"US Bureau of Labor Statistics. 2019. BLS Reports October 2019: Labor force characteristics by race and ethnicity, 2018. United States Department of Labor. https:\/\/www.bls.gov\/opub\/reports\/race-and-ethnicity\/2018\/home.htm [Accessed September 7, 2021]."},{"key":"bib73","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.4049\/jimmunol.1002697","article-title":"Indirect stimulation of human V\u03b32V\u03b42 T cells through alterations in isoprenoid metabolism","volume":"187","author":"Wang","year":"2011","journal-title":"Journal of Immunology"},{"key":"bib74","first-page":"1165","article-title":"The effect of zoledronic acid on the function and differentiation of myeloid cells","volume":"91","author":"Wolf","year":"2006","journal-title":"Haematologica"},{"key":"bib75","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2018.08.070","article-title":"The mevalonate pathway is a druggable target for vaccine adjuvant discovery","volume":"175","author":"Xia","year":"2018","journal-title":"Cell"},{"key":"bib76","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","article-title":"In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19","volume":"32","author":"Zhang","year":"2020","journal-title":"Cell Metabolism"},{"key":"bib77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/cmi.2011.47","article-title":"Bone marrow and the control of immunity","volume":"9","author":"Zhao","year":"2012","journal-title":"Cellular & Molecular Immunology"},{"key":"bib78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135999","article-title":"The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized Mice","volume":"10","author":"Zheng","year":"2015","journal-title":"PLOS ONE"},{"key":"bib79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85049-0","article-title":"The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue","volume":"11","author":"Zimniak","year":"2021","journal-title":"Scientific Reports"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/79548\/elife-79548-v2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/79548\/elife-79548-v2.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/79548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T06:15:49Z","timestamp":1701411349000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/79548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":79,"alternative-id":["10.7554\/eLife.79548"],"URL":"https:\/\/doi.org\/10.7554\/elife.79548","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.06.14.22276397","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2022.06.14.22276397","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2022.06.14.22276397","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.79548.sa1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.79548.sa0","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.79548.sa2","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e79548"}}